AIDS Therapy

Experimental AIDS vaccine seen helping some

Published in Vaccine Weekly, March 19th, 2003

A highly anticipated experimental AIDS vaccine failed to protect most people from the disease in its first major trial, although it did show promise in protecting blacks and Asians, its developer says.

The overall expected rate of infection was not reduced in the high-risk people who volunteered to take the vaccine, VaxGen, Inc. said. However, the expected infection rate for the 314 black volunteers who received the vaccine was reduced by 78% - a finding the researchers said was unexpected. The rate was reduced by 67% for all nonwhite volunteers other than Hispanics.

"This is the first time we have specific numbers to suggest that a vaccine has...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2003-03-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry